Goodwin Procter advised BridgeBio on the deal. BridgeBio announced its definitive agreement with an undisclosed purchaser to sell its rare pediatric disease Priority Review Voucher for $110...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised BridgeBio Pharma, Inc. on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced its exclusive license agreement wit Bristol Myers Squibb to develop and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Ionpath, Inc. on the deal. Thermo Fisher Scientific announced its strategic investment in Ionpath, Inc. Ionpath, Inc., based in Menlo Park, California, is a...
You must be a Standard 1 Year member to access this content.
Holland & Knight advised Future plc on the deal while Goodwin Procter represented Clique Brands. Future plc (LSE: FUTR), the global platform for specialist media, announced its...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Pond5 on the deal, while Cahill advised Shutterstock in the acquisition and in a $100 million revolving credit facility. Pond5 announced its acquisition by...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised York Capital Management on the deal. York Capital Management announced an acquisition through its portfolio company, Cennox, of a group of Dutch-based companies including...
You must be a Standard 1 Year member to access this content.
Goodwin advised Nuvig Therapeutics on the deal. Nuvig Therapeutics announced its $47 million Series A financing and the launch of the company to develop novel therapeutics that...
You must be a Standard 1 Year member to access this content.
Goodwin advised ModeX Therapeutics, Inc. on the deal while Greenberg Traurig represented OPKO Health Inc. ModeX Therapeutics, Inc. announced its sale to OPKO Health, Inc. (NASDAQ: OPK)...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Flagship Pioneering on the deal. Flagship Pioneering announced its collaboration agreement with Novo Nordisk A/S to create a portfolio of novel research programs...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised MOMA Therapeutics on the deal. MOMA Therapeutics announced its completion of a $150 million Series B Financing. MOMA Therapeutics is a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Deliverr, Inc. on the deal, while Paul, Weiss advised Shopify. Deliverr, Inc. announced its agreement to be acquired by Shopify Inc. (NYSE, TSX: SHOP)....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised TA Associates on the deal. TA Associates announced its strategic growth investment in Veracode, taking a majority equity position in the business. Veracode is...
You must be a Standard 1 Year member to access this content.
